Key facts
- Saint Medical Technology’s last known valuation is $121.2M (Nov 2022).
- It has raised $20.8M; the latest was Later Stage VC in Apr 2026.
- Notable investors include Wuxi Capital, Zijin Hi-Tech Venture Capital, Wuxi Jinkong Qiyuan Investment, GP Capital (Shanghai), InnoMed Capital — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Saint Medical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Saint Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Saint Medical Technology
Developer of structural heart disease diagnosis and treatment technology platform and medical devices. The company is committed to building a diagnostic platform and developing innovative medical devices in the field of valvular heart disease, enabling patients with heart disease to get better treatment.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2019
- Employees
- 100
- Website
- saint-medical.com/
- Ownership
- Privately Held (backing)
Saint Medical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Saint Medical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Saint Medical Technology in its N-PORT filings yet. We sweep new filings monthly.